William Richard White, Chief Financial Officer at Akero Therapeutics, Inc. (AKRO), sold 632 shares at $50.34 ($32K) on 2023-09-13, disclosed to the SEC on 2023-09-25.
Scheduled sale ($32k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AKRO | SELL | 2025-06-12 | $151K | — | Filing → |
| AKRO | SELL | 2025-03-14 | $30K | — | Filing → |
| AKRO | SELL | 2024-12-12 | $173K | — | Filing → |